Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Minority Interest (2016 - 2021)

Myriad Genetics has reported Minority Interest over the past 5 years, most recently at -$100000.0 for Q3 2021.

  • Quarterly Minority Interest changed N/A to -$100000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was -$100000.0 through Sep 2021, changed N/A year-over-year, with the annual reading at -$400000.0 for FY2017, N/A changed from the prior year.
  • Minority Interest was -$100000.0 for Q3 2021 at Myriad Genetics, roughly flat from -$100000.0 in the prior quarter.
  • Over five years, Minority Interest peaked at $100000.0 in Q1 2018 and troughed at -$400000.0 in Q2 2017.
  • The 4-year median for Minority Interest is -$100000.0 (2018), against an average of -$133333.3.
  • The largest YoY upside for Minority Interest was 200.0% in 2019 against a maximum downside of 200.0% in 2019.
  • A 4-year view of Minority Interest shows it stood at -$300000.0 in 2017, then surged by 66.67% to -$100000.0 in 2018, then skyrocketed by 200.0% to $100000.0 in 2019, then tumbled by 200.0% to -$100000.0 in 2021.
  • Per Business Quant, the three most recent readings for MYGN's Minority Interest are -$100000.0 (Q3 2021), -$100000.0 (Q2 2021), and $100000.0 (Q4 2019).